ABIONYX Pharma SA (FRA:609)
3.655
-0.210 (-5.43%)
Last updated: Jan 6, 2026, 8:06 AM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €130.35 million as of January 9, 2026. Its market cap has increased by 215.89% in one year.
Market Cap
130.35M
Enterprise Value
131.10M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.66
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 130.35M, a decrease of -39.13%. That is a compound annual growth rate of -4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 130.35M | -2.38% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |